Melissa Schroer, MD
Family Medicine · Cincinnati, OHNPI 1366428849
Payments from drug & device makers
Across 805 payments — averaging $143.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$94K
- Eli Lilly$12K
- AbbVie$2K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- AstraZeneca$1K
- Pfizer$709
- plus $3K from 29 others
What the payments were for
- Consulting fees$32,75028%
- Speaking & faculty fees$61,07553%
- Travel & lodging$10,6909%
- Food & beverage$11,02810%
- Education$1650%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 385 | $94,401 |
| Eli Lilly | 9 | $11,544 |
| AbbVie(2 entities) | 71 | $2,320 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $2,123 |
| AstraZeneca | 39 | $1,306 |
| Pfizer | 88 | $709 |
| Otsuka America Pharmaceutical, Inc. | 25 | $397 |
| Idorsia Pharmaceuticals US Inc | 19 | $312 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 19 | $283 |
| Novo Nordisk | 19 | $229 |
| Astellas Pharma US Inc | 7 | $214 |
| GSK | 11 | $180 |
| Supernus Pharmaceuticals, Inc. | 3 | $175 |
| Exact Sciences | 7 | $153 |
| Amgen | 9 | $145 |
| Abbott | 7 | $138 |
| Merck | 9 | $133 |
| Johnson & Johnson | 8 | $131 |
| Boehringer Ingelheim | 7 | $114 |
| Bayer | 5 | $89 |
| Axsome Therapeutics, Inc. | 4 | $78 |
| Tris Pharma Inc | 5 | $75 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $66 |
| Lundbeck LLC | 3 | $61 |
| Azurity Pharmaceuticals, Inc. | 3 | $53 |
| Sanofi Pasteur Inc. | 3 | $53 |
| Ironshore Pharmaceuticals Inc. | 2 | $36 |
| Zyla Life Sciences, Inc. | 2 | $34 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| Radius Health, Inc. | 2 | $24 |
| Hikma Pharmaceuticals USA | 1 | $19 |
| Biodelivery Sciences International, Inc. | 1 | $16 |
| Cranial Technologies, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$115,708 in reported general payments places this provider in the 95th percentile of 3,983 family medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 44 | $42,549 |
| JardianceEmpagliflozin | 38 | $30,588 |
| MounjaroTirzepatide | 26 | $26,882 |
| FarxigaDapagliflozin Propanediol | 16 | $11,813 |
| TrintellixVortioxetine Hydrobromide | 22 | $10,295 |
| BelbucaBuprenorphine Hcl | 12 | $9,467 |
| BelsomraSuvorexant | 14 | $5,953 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $4,051 |
| Pentazocine-Naloxone HclPentazocine Hcl/Naloxone Hcl | 11 | $3,639 |
| Pregabalin | 38 | $2,158 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 59 | $2,056 |
| Oxycodone Hcl | 107 | $1,902 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 85 | $1,720 |
| Fentanyl | 26 | $1,563 |
| Eszopiclone | 16 | $1,257 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $229 | $42,54944 claims |
| Boehringer IngelheimJardiance | $114 | $30,58838 claims |
| Lilly USA, LLCMounjaro | $94,401 | $26,88226 claims |
| AstraZenecaFarxiga | $1,306 | $11,81316 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $2,123 | $10,29522 claims |
| MerckBelsomra | $133 | $5,95314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Cincinnati
- Michael ButcherCincinnati$18.3M
- Paul NugentCincinnati$4.9M
- Rajesh DavitCincinnati$2M
- Michael HeileCincinnati$272K
- Michael NossCincinnati$265K
- Amy MechleyCincinnati$120K
- William CoxCincinnati$52K
- Frank PerrinoCincinnati$49K
- Sean LyndCincinnati$46K
- Christopher SweeneyCincinnati$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.